PHSA - BCC - PHARM - Hematologic Adverse Effects
After completing this course learners will be able to:
- Understand the pathophysiology of myelosuppression.
- Review the methods for grading myelosuppression.
- Describe the prevention, assessment and management of neutropenia and febrile neutropenia.
- Describe the prevention, assessment and management of thrombocytopenia.
- Describe the prevention, assessment and management of anemia.
- Describe the prevention, identification, and management of other hematologic side effects.
- Categorize cancer therapy agents commonly associated with hematologic toxicities.
Pharmacists at BC Cancer |
|
3 hrs 30 mins | |
5753 |
Contact Info
Mandeep Bains
For technical issues, please submit a ticket through LearningHub Help Site.